Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-85,604
Closed -$197K 550
2020
Q1
$197K Buy
+85,604
New +$310K ﹤0.01% 432
2018
Q3
Sell
-19,174
Closed -$89K 533
2018
Q2
$89K Sell
19,174
-30,308
-61% -$178K ﹤0.01% 506
2018
Q1
$360K Hold
49,482
0.01% 298
2017
Q4
$320K Sell
49,482
-9,810
-17% -$62.8K 0.01% 320
2017
Q3
$391K Buy
59,292
+22,710
+62% +$141K 0.01% 267
2017
Q2
$201K Buy
36,582
+25,687
+236% +$147K ﹤0.01% 346
2017
Q1
$63K Hold
10,895
﹤0.01% 318
2016
Q4
$53K Hold
10,895
﹤0.01% 240
2016
Q3
$66K Buy
+10,895
New +$65.1K ﹤0.01% 206

Other funds holding ABEV

Greenleaf Trust's ABEV Position: Q2 2020 in Review

Greenleaf Trust sold out of Ambev (ABEV) in Q2 2020, closing a stake of 85,604 shares — an estimated $197K sold.

Greenleaf Trust first reported a position in ABEV in Q3 2016 and held it in 9 quarters. The position peaked at $391K in Q3 2017. 272 funds tracked by Wall St. Rank hold ABEV as of Q2 2020.

  • Greenleaf Trust reported no remaining Ambev position as of Q2 2020 after selling out during the quarter.
  • Greenleaf Trust sold 85,604 Ambev shares in Q2 2020, an estimated $197K.
  • Greenleaf Trust first reported a position in Ambev in Q3 2016 and held it in 9 quarters.
  • Greenleaf Trust's Ambev position peaked at $391K in Q3 2017.
  • 272 funds tracked by Wall St. Rank held Ambev as of Q2 2020.

Based on Greenleaf Trust's 13F filing for Q2 2020, filed 12 Aug 2020.